#$%^&*AU2013270636A120140116.pdf#####ABSTRACT The present invention discloses the use of potassium 2-(a-hydroxypentyl) benzoate in the manufacture of medicaments for preventing, relieving or treating senile dementia 5 diseases or symptom, and for relieving oxidative stress injury in brain tissue, increasing neural function of choline, protecting neuron and/or raising the content of brain nerve growth factor. The present invention also discloses a pharmaceutical composition comprising potassium 2-(a-hydroxypentyl) benzoate in prophylactically or therapeutically effective dose, optionally, a pharmaceutically acceptable carrier and/or 10 adjuvant. 4962641_1 (GHMatters) P86139AU.1 16/12113
